@article{5899de4accee48f8b8c36239c3055afa,
title = "In Reply to 'Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study' and 'Binder Wars'",
author = "Wajeh Qunibi and Muenz, {Larry R.} and Diaz-Buxo, {Jose A.}",
note = "Funding Information: Support: The CARE-2 Study was supported by a grant from Fresenius Medical Care North America, Waltham, MA. Funding Information: Financial Disclosure: Dr Qunibi is a consultant and speaker for and a recipient of research support from Fresenius Medical Care, which markets PhosLo. Dr Muenz is a paid consultant to Fresenius Medical Care. Dr Diaz-Buxo is an employee of Fresenius Medical Care.",
year = "2008",
month = nov,
doi = "10.1053/j.ajkd.2008.08.013",
language = "English (US)",
volume = "52",
pages = "1025",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders",
number = "5",
}